Cite
HARVARD Citation
Galluzzo, M. et al. (2018). Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation. Expert opinion on biological therapy. pp. 727-735. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Galluzzo, M. et al. (2018). Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation. Expert opinion on biological therapy. pp. 727-735. [Online].